Today's Breaking News
- Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech
- Novo Nordisk reports positive results from first phase 3 trial with long-acting factor IX for treatment of haemophilia B
- Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
Latest R&D and Business News
- Novartis drug Afinitor significantly extended time without disease progression in women with HER2 positive advanced breast cancer
- AREVA Med Presents Pharmacokinetics Data From Phase 1 Clinical Trial at SNMMI
- A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing
- AbbVie and Galapagos extend GLPG0634 collaboration to include Crohn's disease
- Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy
- Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S.
- Pearl Therapeutics Presents Dose-Ranging, Efficacy and Safety Results of PT003 as well as Components, PT001 and PT005 at American Thoracic Society Meeting
- Alnylam Presents Key Pre-Clinical Proof-of-Concept Data for ALN-AS1, an RNAi Therapeutic Targeting Aminolevulinate Synthase-1 (ALAS-1) for the Treatment of Porphyria
- Additional macitentan (Opsumit) data in pulmonary arterial hypertension presented at ATS
- Safety results from Auris Medical’s clinical development of AM-101 presented at international conference
- SciClone and Zensun Enter Into a Licensing Agreement for Novel Chronic Heart Failure Drug Neucardin(TM) for the China Market
- SIMPONI (GOLIMUMAB) Receives FDA Approval For Ulcerative Colitis